Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):409–416. doi: 10.1097/QAI.0000000000001514

Table 1.

Participant characteristics during first year of observation

Total (N=15,614) MSM (N=7,762) MSW (N=4,099) Women (N=3,753)
N % N % N % N %
Age (years)
 Under 30 1,908 12 1,154 15 263 6 491 13
 30–39 3,623 23 1,949 25 683 17 991 26
 40–49 5,742 37 2,785 36 1,609 39 1,348 36
 50 or older 4,341 28 1,874 24 1,544 38 923 25
Race/ethnicity
 Non-Hispanic White 5,850 37 4,043 52 1,030 25 777 21
 Non-Hispanic Black 6,894 44 2,055 26 2,383 58 2,456 65
 Hispanic 2,286 15 1,282 17 571 14 433 12
 Other 382 5 382 5 115 3 87 2
History of IDU
 No 12,114 78 6,954 90 2,364 58 2,796 75
 Yes 3,500 22 808 10 1,735 42 957 25
Annual HIV care visits
 ≤ 3 8,296 53 4,042 52 2,266 55 1,988 53
 4 to 6 4,725 30 2,381 31 1,187 29 1,157 31
 ≥ 7 2,593 17 1,339 17 646 16 608 16
CD4 count (cells/μl)*
 ≤ 200 3,185 20 1,316 17 1,126 27 743 20
 201 to 350 2,986 19 1,438 19 849 21 699 19
 ≥ 351 9,443 60 5,008 65 2,124 52 2,311 62
HIV RNA (copies/ml)*
 ≤ 400 9,079 58 4,725 61 2,335 57 2,019 54
 > 400 6,535 42 3,037 39 1,764 43 1,734 46

MSM, men who have sex with men; MSW, men who have sex exclusively with women; IDU, injection drug use

*

First measurement of the calendar year